Bioage Labs, Inc. · NASDAQ:BIOA
Barton Shane sold 62,566 Bioage Labs, Inc. shares (Form 4)
Traded Jun 29 to Jun 30, 2026 · Filed Jul 1, 2026
From Jun 29 to Jun 30, 2026, Barton Shane (Principal Accounting Officer) sold 62,566 Bioage Labs, Inc. shares at an average US$25.20 for US$1.58M under a trading plan, leaving 0 shares. Filed Jul 1, 2026 (Form 4).
- Sold
- 62,566 shares
- Price
- US$25.20 average (US$25.19 to US$25.21)
- Value
- US$1.58M
- Holding after
- 0 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Principal Accounting Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 29, 2026 | Common Stock | Option exercise | 9,301 | US$10.85 | 11,933 | Direct |
| Jun 29, 2026 | Common Stock | Option exercise | 7,261 | US$8.39 | 19,194 | Direct |
| Jun 29, 2026 | Common Stock | Option exercise | 8,958 | US$4.30 | 28,152 | Direct |
| Jun 29, 2026 | Common Stock | Option exercise | 14,198 | US$4.38 | 42,350 | Direct |
| Jun 29, 2026 | Common Stock | Sale | 42,350 | US$25.21 | 0 | Direct |
| Jun 30, 2026 | Common Stock | Option exercise | 4,290 | US$10.85 | 4,290 | Direct |
| Jun 30, 2026 | Common Stock | Option exercise | 4,000 | US$8.39 | 8,290 | Direct |
| Jun 30, 2026 | Common Stock | Option exercise | 4,065 | US$4.30 | 12,355 | Direct |
| Jun 30, 2026 | Common Stock | Option exercise | 7,861 | US$4.38 | 20,216 | Direct |
| Jun 30, 2026 | Common Stock | Sale | 20,216 | US$25.19 | 0 | Direct |
Source
Related
- Bioage Labs, Inc.
- Barton Shane
- Bioage Labs, Inc. shareholders
- Schedule 13G/A · Cormorant Asset Management, LP · Aug 14, 2026
- Schedule 13G/A · Cormorant Asset Management, LP · May 15, 2026
- Schedule 13G/A · VK Services, LLC · May 15, 2026
- Schedule 13G · BlackRock, Inc. · Apr 27, 2026
- Form 4 · Goldstein Dov A Md · Apr 24, 2026